• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2025, Vol. 42 ›› Issue (4): 321-324.

• 管理研究 • 上一篇    

海南省临床急需进口药品首次申报常见问题分析

黄冬强, 白凯文   

  1. 海南省药品和医疗器械审评服务中心, 海南 海口 570216
  • 收稿日期:2025-07-18 修回日期:2025-08-17 接受日期:2025-10-10 出版日期:2025-08-28 发布日期:2025-10-11

Analysis of Common Problems in the First Declaration of Clinically Urgent Imported Drugs in Hainan Province

 HUANG Dongqiang, BAI Kaiwen   

  1. Hainan Center for Drug and Medical Device Evaluation and Service,Hainan Haikou 570216, China
  • Received:2025-07-18 Revised:2025-08-17 Accepted:2025-10-10 Online:2025-08-28 Published:2025-10-11

摘要: 《海南自由贸易港建设总体方案》中提出到本世纪中叶,全面建成具有较强国际影响力的高水平自由贸易港,在现代产业体系中要求提升博鳌乐城国际医疗旅游先行区发展水平。在海南自由贸易港的建设背景下,本研究对海南省2022—2024年临床急需进口药品首次申报情况进行梳理,对申请书、资质证明文件、拟进口药品的使用计划文件、专家信息等模块的常见问题进行分析,常见问题表现为资料缺失、资料不明确、资料矛盾、合规性不足4个方面。针对申报资料存在的不足之处,结合海南省临床急需进口药品监管实际,从监管部门和医疗机构角度出发,监管部门可通过推进申报资料标准化模板的建立实施、构建长效化互动机制等方面打造良好的营商环境,积极为行业发展贡献力量;医疗机构可通过建立标准化文件体系、完善申报全流程管控等方面充分发挥申报主体责任,主动提升申报资料质量,监管部门和医疗机构同向发力,赋能医药健康产业高质量发展。

关键词: 海南自由贸易港, 临床急需进口药品, 首次申报, 常见问题

Abstract: The Overall Plan for the Construction of Hainan free trade port proposes to comprehensively build a high-level free trade port with strong international influence by the middle of this century, and to enhance the development level of Boao Lecheng International Medical Tourism Pilot Zone in the modern industrial system.Against the backdrop of the construction of the Hainan free trade port, this article reviews the initial declaration of clinically urgent imported drugs in Hainan province from 2022 to 2024. Common problems in modules such as application forms, qualification certificates, usage plans for imported drugs, and expert information are analyzed. The common problems are manifested in four aspects: missing data, unclear data, conflicting data, and insufficient compliance. In response to the deficiencies in the application materials and in combination with the actual supervision of imported drugs urgently needed in clinical practice in Hainan province, from the perspective of regulatory authorities and medical institutions, regulatory authorities can create a good business environment by promoting the establishment and implementation of standardized templates for application materials, constructing long-term interactive mechanisms, and actively contributing to the development of the industry; medical institutions can fully exert their main responsibility for declaration and actively improve the quality of declaration materials by establishing a standardized document system and improving the control of the entire declaration process; regulatory authorities and medical institutions are working together to empower the high-quality development of the pharmaceutical and health industry.
     [Key Words] 

Key words: Hainan free trade port, Clinically urgent imported drugs, First declaration, Common problem

中图分类号: